Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

NCT02273180 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: SAR342434
DRUG: Humalog
DRUG: Insulin glargine HOE901

Sponsor

Sanofi